Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX) has reported earnings 34 times since Aug 09, 2018. The stock moves an average of ±7.89% the day after reporting, closing higher 41.2% of the time. Its largest post-earnings gain was +28.45% (May 11, 2020) and its largest decline was -19.77% (Nov 06, 2019). The next earnings report is predicted for 2026-10-19 (approximate).
Earnings reactions
How AMRX moved on each past earnings report.
Earnings Impact
Total Earnings
34
Avg Abs. Movement
±7.89%
Positive %
41.2%
Negative %
58.8%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 30, 2026 | ☀ PRE | -3.19% | open_in_new |
| May 07, 2026 | ☽ POST | -3.93% | open_in_new |
| Apr 22, 2026 | ☀ PRE | -1.54% | open_in_new |
| Feb 27, 2026 | ☀ PRE | -4.69% | open_in_new |
Earnings Count
34
Total earnings in dataset
Avg Abs. Movement
±7.89%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| S-3ASR | 20260903 | open_in_new SEC.gov |
| 4 | 20260902 | open_in_new SEC.gov |
| 4 | 20260825 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| 144 | 20260813 | open_in_new SEC.gov |
| 4 | 20260813 | open_in_new SEC.gov |
| 4 | 20260813 | open_in_new SEC.gov |
| 4 | 20260813 | open_in_new SEC.gov |
| 144 | 20260812 | open_in_new SEC.gov |
| 144 | 20260812 | open_in_new SEC.gov |
Frequently asked about AMRX earnings
When does Amneal Pharmaceuticals, Inc. report earnings next? expand_more
Amneal Pharmaceuticals, Inc. (AMRX)'s next earnings date is approximate for 2026-10-19. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AMRX stock move after earnings? expand_more
Over 34 reports, AMRX has moved an average of ±7.89% the session after earnings, closing higher 41.2% of the time.
What was AMRX's biggest post-earnings move? expand_more
AMRX's largest post-earnings gain on record was +28.45% on May 11, 2020, and its largest decline was -19.77% on Nov 06, 2019.
Where can I find Amneal Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Amneal Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right